# Swami S. Iyer

Type: Person

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/swami-s-iyer
Canonical HTML page: https://gethealthbrief.com/entity/swami-s-iyer

## Recent coverage (1 stories)

### Aurobindo’s $250M Lannett Buy Adds 4B Dose Capacity, FTC OKs
2026-07-27 04:41:57 · Sentiment: Bullish · Impact: 6/10 · Sources: 2

FTC approval paves the way for Aurobindo Pharma to acquire Lannett Company, adding a 4 billion dose manufacturing facility and complex non-opioid generics portfolio to its network, directly supporting US efforts to boost domestic drug production and address the opioid crisis.
Full story: https://gethealthbrief.com/story/aurobindo-lannett-ftc-approval-health-impact

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.